AWKNF   $0.17  -19.66% Market Closed

Awakn Life Sciences Corp
Total Cash 712.71K
totalCashPerShare 0.017
EBITDA -2.60M
Total Debt 0.00
quickRatio 0.304
currentRatio 0.35
Total Revenue 82.43K
debtToEquity
Revenue/Share 0.002
ROA -1.82752
ROE
grossProfits
freeCashflow -686.47K
operatingCashflow 2.19M
earningsGrowth
revenueGrowth -0.553
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -52.97299
profitMargins 0.0
enterpriseValue 2.62M
forwardPE
floatShares 34.94M
sharesOutstanding 41.66M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.08%
heldPercentInstitutions 0.06%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.038
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -2.87M
trailingEps -0.06%
forwardEps -0.24%
enterpriseToEbitda -1.01
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 1
lastUpdated Nov. 7, 2024, 5:12 a.m.